Literature DB >> 31405835

Management of ovarian cancer risk in women with BRCA1/2 pathogenic variants.

Melissa Walker1, Michelle Jacobson2, Mara Sobel2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31405835      PMCID： PMC6690830          DOI： 10.1503/cmaj.190281

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  49 in total

1.  Hysterectomy, oophorectomy and risk of dementia: a nationwide historical cohort study.

Authors:  Thien Kieu Thi Phung; Berit Lindum Waltoft; Thomas Munk Laursen; Annette Settnes; Lars Vedel Kessing; Preben Bo Mortensen; Gunhild Waldemar
Journal:  Dement Geriatr Cogn Disord       Date:  2010-07-30       Impact factor: 2.959

2.  Survival patterns after oophorectomy in premenopausal women: a population-based cohort study.

Authors:  Walter A Rocca; Brandon R Grossardt; Mariza de Andrade; George D Malkasian; L Joseph Melton
Journal:  Lancet Oncol       Date:  2006-10       Impact factor: 41.316

3.  Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

Authors:  A Antoniou; P D P Pharoah; S Narod; H A Risch; J E Eyfjord; J L Hopper; N Loman; H Olsson; O Johannsson; A Borg; B Pasini; P Radice; S Manoukian; D M Eccles; N Tang; E Olah; H Anton-Culver; E Warner; J Lubinski; J Gronwald; B Gorski; H Tulinius; S Thorlacius; H Eerola; H Nevanlinna; K Syrjäkoski; O-P Kallioniemi; D Thompson; C Evans; J Peto; F Lalloo; D G Evans; D F Easton
Journal:  Am J Hum Genet       Date:  2003-04-03       Impact factor: 11.025

Review 4.  Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force.

Authors:  Heidi D Nelson; Laurie Hoyt Huffman; Rongwei Fu; Emily L Harris
Journal:  Ann Intern Med       Date:  2005-09-06       Impact factor: 25.391

5.  Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.

Authors:  C Bethan Powell; Eric Kenley; Lee-May Chen; Beth Crawford; Jane McLennan; Charles Zaloudek; Miriam Komaromy; Mary Beattie; John Ziegler
Journal:  J Clin Oncol       Date:  2005-01-01       Impact factor: 44.544

6.  Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause.

Authors:  W A Rocca; J H Bower; D M Maraganore; J E Ahlskog; B R Grossardt; M de Andrade; L J Melton
Journal:  Neurology       Date:  2007-08-29       Impact factor: 9.910

7.  Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy.

Authors:  A Benshushan; N Rojansky; M Chaviv; S Arbel-Alon; A Benmeir; T Imbar; A Brzezinski
Journal:  Climacteric       Date:  2009-10       Impact factor: 3.005

8.  HABITS (hormonal replacement therapy after breast cancer--is it safe?), a randomised comparison: trial stopped.

Authors:  L Holmberg; H Anderson
Journal:  Lancet       Date:  2004-02-07       Impact factor: 79.321

9.  BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer.

Authors:  Michael J Hall; Julia E Reid; Lynn A Burbidge; Dmitry Pruss; Amie M Deffenbaugh; Cynthia Frye; Richard J Wenstrup; Brian E Ward; Thomas A Scholl; Walter W Noll
Journal:  Cancer       Date:  2009-05-15       Impact factor: 6.860

10.  Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers.

Authors:  Timothy R Rebbeck; Noah D Kauff; Susan M Domchek
Journal:  J Natl Cancer Inst       Date:  2009-01-13       Impact factor: 13.506
View more
  2 in total

1.  Dual BRCA1 and BRCA2 pathogenic variants in an adolescent with syndromic intellectual disability.

Authors:  Arash Algouneh; Michelle Caudle; Tugce Balci; Andrea Andrade; Debbie Penava; Maha Saleh
Journal:  Clin Case Rep       Date:  2022-08-08

Review 2.  Hereditary Ovarian Cancer: Towards a Cost-Effective Prevention Strategy.

Authors:  Aruni Ghose; Anita Bolina; Ishika Mahajan; Syed Ahmer Raza; Miranda Clarke; Abhinanda Pal; Elisabet Sanchez; Kathrine Sofia Rallis; Stergios Boussios
Journal:  Int J Environ Res Public Health       Date:  2022-09-23       Impact factor: 4.614
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.